BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 12, 2002
View Archived Issues
Oxxon Pharmaccines licenses MVA technology from Alpharma
Read More
ProdiGene successfully expresses SIV subunit vaccine
Read More
Phase I/II trials of gene therapy cancer vaccine expanded
Read More
Maxim describes discovery, SAR and biological activity of apoptosis inducers at ACS meeting
Read More
Selective metabotropic glutamate mglu2 receptor allosteric potentiators designed at Lilly
Read More
Small-molecule Tie-2 kinase inhibitor exerts antiangiogenic activity in vitro and in vivo
Read More
Synthetic antimicrotubule agent related to hemiasterlin displays excellent pharmacological profile
Read More
PD-205520, an EGF receptor tyrosine kinase inhibitor, undergoes toxicity testing
Read More
Second-generation semisynthetic epothilone analogue enters phase I based on preclinical data
Read More
Potent and selective MRP1 inhibitors considered promising clinical candidates
Read More
Allos licenses N-Gene's chemoprotective agent BGP-15
Read More
Lip'ral technology completes pilot clinical study
Read More
Long-term survival findings reported for Multikine in head and neck cancer
Read More
E.U. approval for Dynastat in postoperative pain
Read More
Sloan-Kettering identifies novel antitumor macrocycles
Read More
TLK-286 enters phase II in breast cancer
Read More
Approvable letter issued for Xyrem in cataplexy
Read More
Study confirms equivalent efficacy for MT-100 and Imitrex in treatment of migraine
Read More
First patients enrolled in SAIK-MS phase II trial in multiple sclerosis
Read More
Phase Ib of TNFerade in solid tumors completes enrollment
Read More
ISTA to proceed with Vitrase NDA filing
Read More
Chemokine CCR3 receptor antagonists for immune, inflammatory disorders patented by Celltech
Read More
Prodrugs of betulinic acid or derivatives designed for the treatment of tumors, HIV
Read More
GABA-A receptor ligands specifically claimed for cognition disorders in recent patent
Read More
New Agouron compounds and methods for treating beta-amyloid-mediated conditions
Read More
Kitasato Institute reports development of antiinflammatory pseudoerythromycin derivatives
Read More
Preparation and use of NK1 receptor antagonists reported by Roche
Read More